Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.
Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check36 days agoChange DetectedSeveral links related to rare diseases and medical resources have been removed, including those for renal cell carcinoma and Cabozantinib.SummaryDifference0.6%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous resources related to rare diseases, including links to PubMed articles and treatment information for renal cell carcinoma, while removing the previous version 2.12.1.SummaryDifference5%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.